Home › Therapeutic areas › Cardiovascular › Dilated Cardiomyopathy
Dilated Cardiomyopathy (3 companies)
Companies with an active program in Dilated Cardiomyopathy.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| LGVN | Longeveron | CardiovascularMetabolic+1 Rare | 1 | Phase 2 | $5.8M | 4 |
| RCKT | Rocket Pharmaceuticals | CardiovascularImmunology Rare | 1 | Approved | $262M | 4 |
| SLDB | Solid Biosciences | CardiovascularNeurology Rare | 3 | Phase 3 | $736M | 6 |
No companies match.